J
John G.F. Cleland
Researcher at National Institutes of Health
Publications - 1276
Citations - 125527
John G.F. Cleland is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Heart failure & Ejection fraction. The author has an hindex of 137, co-authored 1172 publications receiving 110227 citations. Previous affiliations of John G.F. Cleland include Northwestern University & Imperial College London.
Papers
More filters
Journal ArticleDOI
Blood urea nitrogen-to-creatinine ratio in the general population and in patients with acute heart failure
Yuya Matsue,Peter van der Meer,Kevin Damman,Marco Metra,Christopher M. O'Connor,Piotr Ponikowski,John R. Teerlink,Gad Cotter,Beth A. Davison,John G.F. Cleland,Michael M. Givertz,Daniel M. Bloomfield,Howard C. Dittrich,Howard C. Dittrich,Ron T. Gansevoort,Stephan J. L. Bakker,Pim van der Harst,Hans L. Hillege,Dirk J. van Veldhuisen,Adriaan A. Voors +19 more
TL;DR: In this paper, the authors defined the normal range of BUN/creatinine ratio and investigated its clinical significance in patients with acute heart failure (AHF) and found that higher than normal range is associated with worse prognosis independently from both creatinine and BUN.
Journal ArticleDOI
Baseline echocardiographic characteristics of heart failure patients enrolled in a large European multicentre trial (CArdiac REsynchronisation Heart Failure study).
Stefano Ghio,Nick Freemantle,Alessandra Serio,Giulia Magrini,Laura Scelsi,Michele Pasotti,John G.F. Cleland,Luigi Tavazzi +7 more
TL;DR: Interventricular dyssynchrony appears to be an independent characteristic of patients with advanced HF, and is poorly related to clinical, electrocardiographic or standard echocardiographic variable.
Journal ArticleDOI
Diastolic heart failure. Paroxysmal or chronic
TL;DR: A further possibility is that heart failure in patients with diastolic dysfunction might be paroxysmal rather than chronic, and this group of patients may present predominantly to acute units like accident and emergency, coronary care units and intensive Care units and are, therefore, unlikely to figure prominently in the usual outpatient population of chronic systolic left ventricular dysfunction.
Journal ArticleDOI
The safety of an adenosine A(1)-receptor antagonist, rolofylline, in patients with acute heart failure and renal impairment: findings from PROTECT.
John R. Teerlink,Vicente J. Iragui,Jay P. Mohr,Peter E. Carson,Paul J. Hauptman,David H. Lovett,Alan B. Miller,Ileana L. Piña,Scott C. Thomson,Paul D. Varosy,Michael R. Zile,John G.F. Cleland,Michael M. Givertz,Marco Metra,Piotr Ponikowski,Adriaan A. Voors,Beth A. Davison,Gad Cotter,Denise Wolko,Paul DeLucca,Christina M. Salerno,George A. Mansoor,Howard C. Dittrich,Christopher M. O'Connor,Barry M. Massie +24 more
TL;DR: Rolofylline treatment was associated with an increased seizure rate, an anticipated complication of A1-receptor antagonists, which underscores the value of longer follow-up durations for AEs, even for agents with short treatment periods, such as in acute heart failure.
Journal ArticleDOI
High-sensitivity C-reactive protein in chronic heart failure: patient characteristics, phenotypes, and mode of death.
Pierpaolo Pellicori,Pierpaolo Pellicori,Jufen Zhang,Jufen Zhang,Joseph J Cuthbert,Alessia Urbinati,Parin Shah,Syed Kazmi,Andrew L. Clark,John G.F. Cleland,John G.F. Cleland +10 more
TL;DR: In patients with CHF, a raised plasma hsCRP is associated with more congestion and a worse prognosis, and the proportion of deaths that are non-CV also increases with higher hs CRP.